DNL343 - AN OVERVIEW

Right here we clearly show that DNL343 minimizes ISR activation and neurodegeneration brought on acutely by an optic nerve crush (ONC) personal injury or chronically by a germline eIF2B LOF mutation in mice. We also display that DNL343 procedure, initiated at a late stage of condition which more correctly replicates a medical dosing paradigm, rever